ARGX
Closed
Argenx Nv Adr
542.47
-8.75 (-1.59%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 551.22
Day's Range: 541.95 - 563.36
Send
sign up or login to leave a comment!
When Written:
372.58
argenx NV is a biotechnology company that develops antibody-based therapies for the treatment of autoimmune diseases and cancer. The company's lead product candidate, efgartigimod, is being developed for the treatment of myasthenia gravis and other autoimmune diseases. Argenx NV is headquartered in Belgium and has operations in the Netherlands and the United States. The company's ADRs (American Depository Receipts) trade on the NASDAQ Global Select Market under the ticker symbol "ARGX." As of August 2021, the company had a market capitalization of over $20 billion.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








